These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36812661)
21. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma. Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851 [TBL] [Abstract][Full Text] [Related]
22. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma. Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814 [TBL] [Abstract][Full Text] [Related]
23. Second cancers among long-term survivors of non-Hodgkin's lymphoma. Travis LB; Curtis RE; Glimelius B; Holowaty E; Van Leeuwen FE; Lynch CF; Adami J; Gospodarowicz M; Wacholder S; Inskip P J Natl Cancer Inst; 1993 Dec; 85(23):1932-7. PubMed ID: 8230284 [TBL] [Abstract][Full Text] [Related]
24. The interrelationship between Hodgkin's disease and non-Hodgkin's lymphomas. Jaffe ES; Zarate-Osorno A; Kingma DW; Raffeld M; Medeiros LJ Ann Oncol; 1994; 5 Suppl 1():7-11. PubMed ID: 8172822 [TBL] [Abstract][Full Text] [Related]
25. Non-Hodgkin's lymphoma involving the vagina: a clinicopathologic analysis of 14 patients. Vang R; Medeiros LJ; Silva EG; Gershenson DM; Deavers M Am J Surg Pathol; 2000 May; 24(5):719-25. PubMed ID: 10800991 [TBL] [Abstract][Full Text] [Related]
26. Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma. Hendry L; Bowen A; Matutes E; Swansbury J; Catovsky D Leuk Lymphoma; 2004 May; 45(5):945-50. PubMed ID: 15291353 [TBL] [Abstract][Full Text] [Related]
27. Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients. Amini RM; Enblad G; Sundström C; Glimelius B Int J Cancer; 1997 May; 71(4):510-6. PubMed ID: 9178801 [TBL] [Abstract][Full Text] [Related]
28. Second malignancies after treatment of diffuse large B-cell non-Hodgkin's lymphoma: a GISL cohort study. Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Gobbi PG; Angrilli F; Brugiatelli M; Musto P; Federico M Haematologica; 2008 Sep; 93(9):1335-42. PubMed ID: 18698083 [TBL] [Abstract][Full Text] [Related]
29. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function? Hemminki K; Jiang Y; Steineck G Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955 [TBL] [Abstract][Full Text] [Related]
30. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma. Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942 [TBL] [Abstract][Full Text] [Related]
31. Effect of human T-lymphotropic virus type I infection on non-Hodgkin's lymphoma incidence. Cleghorn FR; Manns A; Falk R; Hartge P; Hanchard B; Jack N; Williams E; Jaffe E; White F; Bartholomew C J Natl Cancer Inst; 1995 Jul; 87(13):1009-14. PubMed ID: 7629870 [TBL] [Abstract][Full Text] [Related]
32. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases. Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110 [TBL] [Abstract][Full Text] [Related]
33. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Miller DC; Hochberg FH; Harris NL; Gruber ML; Louis DN; Cohen H Cancer; 1994 Aug; 74(4):1383-97. PubMed ID: 8055462 [TBL] [Abstract][Full Text] [Related]
34. The relationship between Hodgkin's disease and non-Hodgkin's lymphoma. Harris NL Semin Diagn Pathol; 1992 Nov; 9(4):304-10. PubMed ID: 1480853 [TBL] [Abstract][Full Text] [Related]
35. Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. Eltom MA; Jemal A; Mbulaiteye SM; Devesa SS; Biggar RJ J Natl Cancer Inst; 2002 Aug; 94(16):1204-10. PubMed ID: 12189223 [TBL] [Abstract][Full Text] [Related]
36. Occupational risk factors for subgroups of non-Hodgkin's lymphoma. Tatham L; Tolbert P; Kjeldsberg C Epidemiology; 1997 Sep; 8(5):551-8. PubMed ID: 9270958 [TBL] [Abstract][Full Text] [Related]
37. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends. Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423 [TBL] [Abstract][Full Text] [Related]
38. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis. Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751 [TBL] [Abstract][Full Text] [Related]
39. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012). Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907 [TBL] [Abstract][Full Text] [Related]
40. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive. Li L; Hamilton L; Montgomery J; Stewart M J Laryngol Otol; 2020 May; 134(5):460-462. PubMed ID: 32308160 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]